Sinopharm
1099.HK
#2294
Rank
โ‚น726.35 B
Marketcap
โ‚น232.76
Share price
-1.96%
Change (1 day)
0.17%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Earnings for Sinopharm (1099.HK)

Earnings in 2024: โ‚น208.09 Billion

According to Sinopharm's latest financial reports the company's current earnings are โ‚น80.09 Billion. In 2024 the company made an earning of โ‚น208.09 Billion a decrease over its 2023 earnings that were of โ‚น288.46 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Sinopharm from 2006 to 2024

Annual earnings

Year Earnings Change
2024โ‚น208.09 B-27.86%
2023โ‚น288.46 B-0.73%
2022โ‚น290.58 B-1.72%
2021โ‚น295.65 B11.7%
2020โ‚น264.68 B18.44%
2019โ‚น223.47 B10.85%
2018โ‚น201.60 B3.05%
2017โ‚น195.63 B36.48%
2016โ‚น143.34 B7.11%
2015โ‚น133.83 B12.38%
2014โ‚น119.09 B25.05%
2013โ‚น95.23 B22.54%
2012โ‚น77.72 B35.43%
2011โ‚น57.38 B52.24%
2010โ‚น37.69 B30.99%
2009โ‚น28.77 B60.59%
2008โ‚น17.91 B48.29%
2007โ‚น12.08 B123.29%
2006โ‚น5.41 B